Diarrhea News and Research

Latest Diarrhea News and Research

Scientists find better treatment options for patients with advanced colorectal cancer

City of Hope, a world-renowned cancer research and treatment organization, today announced study results of a Phase 2 clinical trial showing monotherapy with sotorasib resulted in anti-tumor activity and a favorable benefit-risk profile among heavily pretreated patients with advanced colorectal cancer. The research was published today in Lancet Oncology.

16 Dec 2021

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

A drug combination can safely prevent transplanted stem cells, known as a graft, from attacking the recipient's body, allowing them to develop into healthy new blood and immune cells, a new study shows.

14 Dec 2021

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

New research from the University of Virginia School of Medicine sheds light on why a fecal transplant can benefit patients with dangerous recurrent C. difficile infections – and suggests a way to improve patient outcomes.

14 Dec 2021

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

Researchers published a report wherein they assessed the symptomology post a booster dose of mRNA vaccines in adults with IBD.

10 Dec 2021

Woman's race/ethnicity and menopause status may partially determine the severity of GI symptoms

Hormonal changes during the menopause transition have been shown to affect a woman's gastrointestinal (GI) functions with some unpleasant results such as nausea, bloating, and abdominal pain.

8 Dec 2021

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

A new case study on the report of multisystem inflammatory syndrome (MISC) in a 22-year-old woman in South Korea after vaccination.

5 Dec 2021

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Researchers at Washington University School of Medicine in St. Louis have identified a drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.

1 Dec 2021

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Researchers compared the distribution of SARS-CoV-2 genotypes to the prevalence of SARS-CoV-2 variants.

28 Nov 2021

Using metal nanoparticles to fight SARS-CoV-2

A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.

25 Nov 2021

Bioinformatics analysis identifies pathways involved in intestinal SARS-CoV-2 infection

Researchers recently used bioinformatics analysis techniques to explore the diseases caused by SARS-CoV-2 infection in the human digestive tract.

22 Nov 2021

Sheep at low-risk for infection with SARS-CoV-2

A team of scientists from the US has recently evaluated the susceptibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in sheep. The findings reveal that sheep are generally less susceptible to SARS-CoV-2 infection. However, the susceptibility is relatively higher for the alpha variant of the virus. The study is currently available on the bioRxiv preprint server.

21 Nov 2021

CDC posts food safety alert about multistate outbreak of E. coli O157 infections linked to spinach

A CDC food safety alert regarding a multistate outbreak of E. coli O157 infections linked to spinach has been posted: https://www.cdc.gov/ecoli/2021/o157h7-11-21/index.html.

20 Nov 2021

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

A new study determines the safety of an additional vaccine among individuals who previously received two doses of mRNA-based COVID-19 vaccines.

15 Nov 2021

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Researchers from China reported the results of their study aimed at finding an effective Mpro inhibitor since Mpro is the best drug target to fight SARS-CoV-2 infection.

12 Nov 2021

Combination treatment improves overall survival for melanoma patients with brain metastases

Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.

11 Nov 2021

Diarrhea News and Research

Latest Diarrhea News and Research

Scientists find better treatment options for patients with advanced colorectal cancer

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

Woman's race/ethnicity and menopause status may partially determine the severity of GI symptoms

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Using metal nanoparticles to fight SARS-CoV-2

Bioinformatics analysis identifies pathways involved in intestinal SARS-CoV-2 infection

Sheep at low-risk for infection with SARS-CoV-2

CDC posts food safety alert about multistate outbreak of E. coli O157 infections linked to spinach

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Combination treatment improves overall survival for melanoma patients with brain metastases

The autoantibody profile in COVID-19 patients with MIS-C

Researchers identify new symptoms associated with pancreatic cancer

The importance of exercise for those with diabetes in the COVID era

What are the risk factors for severe disease in children hospitalized for SARS-CoV-2 infection?

Factors predicting cognitive symptoms in long COVID

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Diarrhea News and Research

Latest Diarrhea News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in